story of the week
High-Dose Chemotherapy With HSCT for High-Risk Breast Cancer and Four or More Involved Axillary Lymph Nodes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial
JAMA Oncol 2020 Jan 30;[EPub Ahead of Print], TG Steenbruggen, LC Steggink, CM Seynaeve, JJM van der Hoeven, MJ Hooning, A Jager, IR Konings, JR Kroep, WM Smit, VCG Tjan-Heijnen, E van der Wall, AD Bins, SC Linn, M Schaapveld, JN Jacobse, FE van Leeuwen, CP Schröder, H van Tinteren, EGE de Vries, GS Sonke, JA GietemaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.